Danaher Corporation $DHR Shares Bought by Police & Firemen s Retirement System of New Jersey

Police & Firemen s Retirement System of New Jersey lifted its stake in shares of Danaher Corporation (NYSE:DHRFree Report) by 3.2% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 96,902 shares of the conglomerate’s stock after purchasing an additional 2,961 shares during the period. Police & Firemen s Retirement System of New Jersey’s holdings in Danaher were worth $19,142,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in DHR. Red Tortoise LLC raised its holdings in shares of Danaher by 175.0% in the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares in the last quarter. Ramirez Asset Management Inc. purchased a new position in Danaher in the second quarter valued at $40,000. Costello Asset Management INC acquired a new stake in Danaher in the first quarter valued at $41,000. Mowery & Schoenfeld Wealth Management LLC lifted its holdings in Danaher by 53.8% during the 1st quarter. Mowery & Schoenfeld Wealth Management LLC now owns 203 shares of the conglomerate’s stock worth $42,000 after buying an additional 71 shares during the last quarter. Finally, Strengthening Families & Communities LLC boosted its position in shares of Danaher by 81.4% during the 1st quarter. Strengthening Families & Communities LLC now owns 254 shares of the conglomerate’s stock worth $52,000 after acquiring an additional 114 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 1.8%

NYSE DHR opened at $219.60 on Thursday. The firm’s fifty day moving average is $204.76 and its two-hundred day moving average is $200.77. Danaher Corporation has a one year low of $171.00 and a one year high of $258.23. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. The firm has a market cap of $155.11 billion, a PE ratio of 45.28, a P/E/G ratio of 3.28 and a beta of 0.81.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. The firm had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business’s revenue was up 4.4% on a year-over-year basis. During the same quarter last year, the company posted $1.71 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Friday, September 26th. Danaher’s dividend payout ratio is 26.39%.

Analyst Ratings Changes

Several equities research analysts recently weighed in on DHR shares. Cowen restated a “buy” rating on shares of Danaher in a research note on Wednesday, October 22nd. Guggenheim restated a “buy” rating and issued a $250.00 target price on shares of Danaher in a report on Wednesday, July 23rd. Redburn Partners set a $220.00 price target on shares of Danaher in a research note on Wednesday, October 8th. TD Cowen boosted their price target on shares of Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Finally, Evercore ISI upped their price objective on shares of Danaher from $226.00 to $245.00 and gave the company an “outperform” rating in a research note on Tuesday, October 7th. Eighteen equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $243.39.

Get Our Latest Stock Report on Danaher

Insider Buying and Selling at Danaher

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Georgeann Couchara sold 5,174 shares of the business’s stock in a transaction on Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the completion of the transaction, the senior vice president directly owned 2,625 shares in the company, valued at $552,352.50. This represents a 66.34% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 11.20% of the stock is owned by company insiders.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.